AbbVie (ABBV) Other Operating Expenses (2012 - 2026)
AbbVie (ABBV) recorded Other Operating Expenses of $2.64 billion in Q2 2026, down 10.1% from $2.93 billion a year earlier and down 18.1% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Other Operating Expenses (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's Other Operating Expenses came in at $14.48 billion as of Jun 30, 2026, down 8.4% year-over-year; for FY2025, it came in at $13.87 billion, down 10.7% from FY2024.
- Annual Other Operating Expenses has a five-year compound annual growth rate of 12.3% (FY2020 to FY2025).
- Across earlier years, Other Operating Expenses came in at $15.54 billion in FY2024 (+87.8%), $8.27 billion in FY2023 (+13.9%), $7.26 billion in FY2022 (-14.3%) and $8.48 billion in FY2021 (+9.3%).
- The Q2 2026 figure is the lowest quarterly Other Operating Expenses since Q1 2025.
- On a year-over-year basis, Other Operating Expenses rose in six of the last eight quarters, with growth averaging 51.4%.
- Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 277.6% in Q4 2024, against a decline of 56.5% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.22 billion (Q1 2026), $3.63 billion (Q4 2025) and $5 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 137.20 Bn | 109.19 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.00 Mn |
| Mar 31, 2026 | 4.96 Bn |
| Dec 31, 2025 | 217.00 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | 4.25 Bn |
| Dec 31, 2024 | 7.00 Mn |
| Jun 30, 2023 | 169.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | -229.00 Mn |
| Jun 30, 2022 | 172.00 Mn |
| Sep 30, 2021 | -500.00 Mn |
| Jun 30, 2021 | 68.00 Mn |
| Mar 31, 2021 | 4.40 Bn |
| Mar 31, 2020 | 1.94 Bn |
| Dec 31, 2019 | 890.00 Mn |
| Mar 31, 2019 | 1.85 Bn |
| Dec 31, 2018 | -1.00 Bn |
| Jun 30, 2018 | 500.00 Mn |
| Mar 31, 2018 | 2.00 Bn |
API Access
AbbVie Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();